Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
InfectologiaSobre o estudo
- Desenho
- Diretriz clínica
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- MMWR. Morbidity and mortality weekly report
- Publicado em
- 28 ago 2025
- Citações
- 63
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Use of Clesrovimab for Prevention of Severe Respiratory Syncytial Virus-Associated Lower Respiratory Tract Infections in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2025
Danielle L Moulia, Ruth Link-Gelles, Helen Y Chu, Denise Jamieson, Oliver Brooks, Sarah Meyer, Eric S Weintraub, David K Shay, Mila M Prill, Ebony S Thomas et al.
Descritores MeSH
- Antibodies, Monoclonal
- Respiratory Tract Infections
- Respiratory Syncytial Virus Infections
- Antibodies, Monoclonal, Humanized
- Infant
- Infant, Newborn
- Pregnancy
- Respiratory Syncytial Virus Vaccines
- United States
- Advisory Committees